Controlled Substances Market Estimated to Flourish by 2025

Press Release

A drug or other drug that is closely government-controlled because it may be abused or addictive is termed as a controlled substance. The control applies to the form, use, handling, storage, and distribution of the substance. A Controlled Substance Ordering System (CSOS) represents a form of digital identity eligible for the electronically ordering of controlled substances in accordance with Schedules I, II, III and IV by the CSOS certification authority of the Drug Enforcement Administration.

Opioids, stimulants, depressants, hallucinogens and anabolic steroids are all controlled substances. Only licensed medical professionals prescribe controlled substances known for medical use, such as morphine, Valium and Ritalin. There is no known medical use for other controlled substances, like heroin and LSD, and they are illegal in the USA.

The report offers a detailed study of the global Controlled Substances Market, considering its growth factors, possible restraints, and potential business prospects.

The NSDUH (National Drug Use & Health Survey) says that approximately last year. Using the prescription controlled substance for non-medical purposes are 2.4 million people in the United States. Due to the increasing number of controlled substance test laboratories in different geographies and the increasing use of illegal medicines via prescription drugs of patients and associated patients, controlled substances are projected to grow at a lucrative rate over the prediction period.

Request to View Brochure of Report –


Although laws and agreements prohibiting the use of marijuana, momentum for global legalization has steadily increased. At first, much of this push was used for medicinal marijuana, but there has also been a substantial support for adult recreation. In different states of the U.S., approved medical marijuana, which had recently been legalized for recreational and medicinal purposes in Canada, was significantly increased. In conjunction with efforts by leading manufacturers of controlled substances to remove legal barriers and attract investor interest, it has made a huge contribution to cannabis populations.

The global controlled substances market for further study is segmented into Europe, North America, Asia Pacific, and Rest of the World. Among these, North America is expected to hold significant market share over the forecast period, due to anticipated high drug use. Europe and Asia-Pacific are considered to be potential markets due to high awareness, with the U.K contributing to the market due to high use of codeine in the region.

Request to View ToC of the report –


Vendors in the global controlled substances market are anticipated to engage in various organic and non-organic growth strategies. The industry with collaborations and partnerships with as cannabis producers compete on the basis of their research initiatives. Leading vendors in the global controlled substances market are PM Pharmaceuticals Inc, Genzyme Corporation, Albany Molecular Research Inc. (AMRI), Glatt Air Techniques , Inc., and Patheon Inc.


Related Articles